Other and unspecified drug induced movement disorders
ICD-10 G25.7 is a billable code used to indicate a diagnosis of other and unspecified drug induced movement disorders.
G25.7 encompasses a range of movement disorders that are induced by the use of various medications, particularly those affecting the dopaminergic system. These disorders can manifest as tremors, rigidity, bradykinesia, and other abnormal movements that resemble Parkinson's disease or extrapyramidal symptoms. The condition is often associated with the use of antipsychotic medications, antiemetics, and other drugs that influence neurotransmitter activity in the brain. The clinical presentation may vary widely, from mild symptoms that are easily managed to severe cases that significantly impair daily functioning. Accurate diagnosis requires a thorough patient history, including a detailed medication review, as well as neurological examination to differentiate drug-induced movement disorders from primary movement disorders such as Parkinson's disease. Treatment typically involves adjusting the offending medication, introducing dopaminergic agents, or utilizing anticholinergic medications to alleviate symptoms. Understanding the nuances of these disorders is crucial for effective management and coding.
Comprehensive neurological examination findings, detailed medication history, and response to treatment.
Patients presenting with new-onset tremors after starting antipsychotic medications.
Differentiating between drug-induced movement disorders and primary neurological conditions is critical.
Thorough documentation of psychiatric medications prescribed and their dosages.
Patients experiencing extrapyramidal symptoms after initiation of antipsychotic therapy.
Understanding the side effects of psychiatric medications is essential for accurate diagnosis.
Used for follow-up visits to assess medication-induced movement disorders.
Document the patient's medication history and current symptoms.
Neurologists should focus on neurological assessments and medication adjustments.
Document the patient's medication history, the onset of symptoms in relation to medication use, and any neurological assessments performed to differentiate from primary movement disorders.
